1. <cite id="cxgj0"></cite>
    +86 400-821-9890

    Vision

    We are devoted to providing the most comprehensive and
    accurate molecular diagnostic information for every cancer
    patient and for physicians to help patients get
    personalized treatment.

    Mission

    Genomic Testing

    We collaborate with hospitals and
    institutes by providing
    comprehensive genomic testing in
    our CLIA-certificated and CAP-
    accredited laboratory.

    Pharmaceutical
    Partnership

    We partner with pharmaceutical
    companies all over the world throughout
    research, biomarker-driven drug
    development and commercialization of
    new cancer therapies.

    Big Data Platform

    As one of the largest genomic
    datasets in China, we build datasets
    of Chinese cancer patients to
    advance medical research and new
    drug development.

    Genomic Testing

    We provide comprehensive tumor genomic testing to assist in personal treatment
    approaches that are recognized as targeted therapies and immunotherapies.

    Biomarker Discovery

    Fusion-Based Biomarkers
    for Targeted Therapy

    We have integrated DNA and RNA sequencing results
    for detection of fusion genes with higher sensitivity.

    IO Biomarkers

    We have leveraged multiple techniques (DNA, RNA,
    IHC, etc.) to help identify immunotherapy-related
    biomarkers for our patients.

    Laboratory

    OrigiMed has 43,000 square feet of lab
    space which has been built in line with
    international standards and 54,000 sq.ft
    of office space.

    43,000 sq.ftLab Space
    4PBStorage Capacity
    110 TFLOPSTotal Peak Performance
    2,304 CoresCPU Core Number
    20.4 TBTotal Memory

    Accreditation

    CAP-accredited
    by The College of
    American Pathologists

    CLIA-certificated
    by The Centers for
    Medicare & Medicaid
    Service

    NIH/CPTAC
    Collaboration

    CSCO-OrigiMed Cancer
    Genomics Data
    Platform for Chinese
    cancer patients

    CTONG-OrigiMed
    New Clinical Trial
    Sharing Platform

    怎样网上赚钱 471| 105| 960| 837| 924| 99| 246| 840| 423| 117| 798| 480| 957| 816| 90| 219| 387| 339| 861| 51| 786| 3| 180| 540| 369| 72| 243| 243| 894| 27| 186| 483| 96| 984| 558| 783| 621| 696| 180| 906| 225|